Home  |  Contact

UniProtKB/Swiss-Prot Q9UGJ0: Variant p.Arg302Gln

5'-AMP-activated protein kinase subunit gamma-2
Gene: PRKAG2
Variant information

Variant position:  302
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Arginine (R) to Glutamine (Q) at position 302 (R302Q, p.Arg302Gln).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and basic (R) to medium size and polar (Q)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In WPWS and CMH6; impaired AMP- and ATP-binding.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.

Sequence information

Variant position:  302
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  569
The length of the canonical sequence.

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.



Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

Chain 1 – 569 5'-AMP-activated protein kinase subunit gamma-2
Domain 275 – 335 CBS 1
Binding site 302 – 302 ADP 2
Binding site 302 – 302 AMP 2
Binding site 302 – 302 ATP 1
Binding site 302 – 302 ATP 2

Literature citations

CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations.
Scott J.W.; Hawley S.A.; Green K.A.; Anis M.; Stewart G.; Scullion G.A.; Norman D.G.; Hardie D.G.;
J. Clin. Invest. 113:274-284(2004)

Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.
Gollob M.H.; Green M.S.; Tang A.S.-L.; Gollob T.; Karibe A.; Al Sayegh A.H.; Ahmad F.; Lozado R.; Shah G.; Fananapazir L.; Bachinski L.L.; Roberts R.;
N. Engl. J. Med. 344:1823-1831(2001)
Cited for: VARIANT WPWS GLN-302;

Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
Arad M.; Benson D.W.; Perez-Atayde A.R.; McKenna W.J.; Sparks E.A.; Kanter R.J.; McGarry K.; Seidman J.G.; Seidman C.E.;
J. Clin. Invest. 109:357-362(2002)
Cited for: VARIANTS CMH6 GLN-302; ASN-400 AND ILE-488;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.